Investment case
Centene Corporation
CNC · 27 developments mapped · last assessed 2026-09-18
Market Ontology has mapped 27 macro, policy, and market developments to Centene Corporation since 2026-08-17. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.
Valuation
No validated run has been published for CNC yet, so no modelled value is shown. The CNC valuation is in the public catch-up queue.
Subscribers do not wait for the weekly cycle: they run CNC on demand, against live prices and the latest filings, and change any assumption the developments below move.
Filed financials
Current case
- Strongest support
Centene Restructures Medicare Advantage Footprint to Target 2027 Margin Breakeven
Direct operational restructuring aimed at improving segment profitability.
· Moves future profitability of medicare advantage segment, sustainability of medical loss ratio improvements, long term growth trajectory post restructuring
- Open question
Centene Posts $2.51 Q2 EPS as Medical Cost Turnaround Offsets 8%-9% Medicaid Shrinkage
Direct financial performance and forward guidance on segment mix.
· Moves revenue growth rate (medicaid vs. marketplace), medical loss ratio (mlr) trends, earnings per share trajectory
What changed, by assumption
- 2026-09-18Centene Posts $2.51 Q2 EPS as Medical Cost Turnaround Offsets 8%-9% Medicaid Shrinkage
- 2026-09-18Centene posts $2.51 Q2 EPS as Medicaid rolls shrink 8%-9% in 2026
- 2026-09-18Centene posts Q2 adjusted EPS of $2.51 amid 8%-9% projected Medicaid roll-off
- 2026-09-18Centene Delivers Q2 Adjusted EPS of $2.51, Projects 8%-9% Medicaid Drop
- 2026-09-18Centene Delivers $2.51 Q2 EPS as Commercial Margins Offset 9% Medicaid Decline
- 2026-09-18Centene posts Q2 EPS turnaround to $2.51 as Medicaid rolls off 8% to 9%
Assumption changes
Full ledger →| Date | Assumption | Direction | Why | Conf. |
|---|---|---|---|---|
| 2026-09-16 | Margin | Bullish | Reaffirmation of adjusted EPS guidance suggests stable or improving margins despite healthcare summit volatility. | 0.80 |
| 2026-07-29 | Net debt | Bearish | Liability-management transactions often reduce gross debt or push maturities out. | 0.70 |
| 2026-07-29 | Interest expense | Bearish | Tender/exchange extends maturity profile and typically lowers near-term interest expense. | 0.70 |
| 2026-06-22 | Share count | Bullish | Stock component of consideration dilutes existing acquirer holders. | 0.70 |
| 2026-06-22 | Net debt | Bullish | Cash component of consideration is typically debt-funded, raising net debt. | 0.70 |
| 2026-06-22 | Revenue | Bullish | Acquisition adds target revenue to acquirer P&L on close. | 0.70 |
Event impact log
Full ledger →| Date | Mechanism | Direction | Horizon | Impact |
|---|---|---|---|---|
| 2026-09-18 | Centene Posts $2.51 Q2 EPS as Medical Cost Turnaround Offsets 8%-9% Medicaid Shrinkage | mixed | 3-12m | 0.80 |
| 2026-09-18 | Centene posts $2.51 Q2 EPS as Medicaid rolls shrink 8%-9% in 2026 | mixed | 3-12m | 0.80 |
| 2026-09-18 | Centene posts Q2 adjusted EPS of $2.51 amid 8%-9% projected Medicaid roll-off | mixed | 3-12m | 0.80 |
| 2026-09-18 | Centene Delivers $2.51 Q2 EPS as Commercial Margins Offset 9% Medicaid Decline | mixed | 1-3m | 0.80 |
| 2026-09-18 | Centene posts Q2 adjusted EPS of $2.51 as Medicaid rolls face 8%-9% 2026 decline | mixed | 3-12m | 0.70 |
| 2026-09-18 | Centene Delivers Q2 Adjusted EPS of $2.51, Projects 8%-9% Medicaid Drop | mixed | 3-12m | 0.70 |
| 2026-09-18 | Centene posts Q2 EPS turnaround to $2.51 as Medicaid rolls off 8% to 9% | mixed | 3-12m | 0.80 |
| 2026-09-18 | Centene posts $2.51 Q2 EPS while managing projected 8-9% Medicaid membership decline | mixed | 3-12m | 0.80 |
| 2026-09-16 | Centene Corporation Reaffirms Full Year 2026 EPS Guidance | Bullish | 1-3m | 0.70 |
| 2026-09-14 | Centene Restructures Medicare Advantage Footprint to Target 2027 Margin Breakeven | Bullish | 1-3m | 0.80 |
| 2026-09-14 | Centene Restructures Medicare Advantage Footprint to Target 2027 Margin Breakeven | watch | 3-12m | 0.60 |
| 2026-09-13 | Centene Improves Medicare HBR to 89.5% via Footprint Simplification | Bullish | 3-12m | 0.80 |